New England Biolabs, Inc. 240 County Road, Ipswich, MA 01938, USA.
New England Biolabs, Inc. 240 County Road, Ipswich, MA 01938, USA.
Eur J Med Chem. 2014 Dec 17;88:34-41. doi: 10.1016/j.ejmech.2014.07.041. Epub 2014 Jul 14.
Ligand binding promotes conformational rearrangement of the epidermal growth factor receptor (EGFR) leading to receptor autophosphorylation and downstream signaling. However, transient interactions between unstimulated EGFR molecules on the cell surface are not fully understood. In this report, we describe the investigation of homodimer formation of EGFR by means of an SNAP-tag based selective crosslinking approach (S-CROSS). EGFR homodimers were selectively captured in living cells and utilized for analysis of protein receptor interactions on the plasma membrane and ligand-induced activation. We showed that EGFR forms homodimers in unstimulated cells with efficiencies similar to those seen in cells treated with the epidermal growth factor ligand (EGF) supporting the existence of constitutive transient receptor-receptor interactions. EGFR crosslinked homodimers displayed a substantially increase in kinase activation upon ligand stimulation. Interestingly, in unstimulated cells the levels of spontaneous phosphorylation were found to correlate with the yields of the crosslinked homodimers species. In addition, we demonstrated that this crosslinking approach can be applied to interrogate the effect of small molecule inhibitors on receptor dimerization and kinase activity. Our crosslinking assay provides a new tool to dissect ligand-independent dimerization and activation mechanisms of receptor tyrosine kinases, many of which are important anticancer drug targets.
配体结合促进表皮生长因子受体(EGFR)的构象重排,导致受体自身磷酸化和下游信号转导。然而,细胞表面未受刺激的 EGFR 分子之间的瞬时相互作用尚未完全了解。在本报告中,我们描述了使用基于 SNAP 标签的选择性交联方法(S-CROSS)研究 EGFR 同源二聚体形成的情况。EGFR 同源二聚体在活细胞中被选择性捕获,并用于分析质膜上的蛋白质受体相互作用和配体诱导的激活。我们表明,EGFR 在未受刺激的细胞中形成同源二聚体的效率与用表皮生长因子配体(EGF)处理的细胞中观察到的效率相似,支持存在组成型瞬时受体-受体相互作用。配体刺激后,EGFR 交联的同源二聚体的激酶活性显著增加。有趣的是,在未受刺激的细胞中,自发磷酸化水平与交联同源二聚体的产量相关。此外,我们证明这种交联方法可用于研究小分子抑制剂对受体二聚化和激酶活性的影响。我们的交联测定为剖析受体酪氨酸激酶的配体非依赖性二聚化和激活机制提供了一种新工具,其中许多是重要的抗癌药物靶标。